Subgroup analysis of JCOG0501 phase III study to confirm superiority of additional neoadjuvant chemotherapy with S-1 plus cisplatin to D2 gastrectomy with S-1 adjuvant chemotherapy for resectable type ...
Please provide your email address to receive an email when new articles are posted on . Among patients with T1 colorectal cancer, deep submucosal invasion was not a significant independent predictor ...
A phase II, open-label, randomized study to evaluate the efficacy and safety of andecaliximab combined with nivolumab versus nivolumab alone in subjects with unresectable or recurrent gastric or ...
ESD is performed with a thin, flexible endoscope inserted through the mouth or rectum. Using miniature tools, clinicians inject fluid to lift a precancerous or early cancer lesion from surrounding ...
Colorectal lesions may be benign, premalignant or malignant. Patients may be asymptomatic or may present with blood in the stool, change in bowel habit, abdominal pain or unexplained weight loss. In ...
Evidence-based recommendations on endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) of non-ampullary duodenal lesions. This involves using a long camera inserted through ...
Submucosal tunneling endoscopic resection (STER) allows GIST removal without traditional surgery, reducing recovery time and complications. STER involves creating a tunnel in the stomach's innermost ...
Please provide your email address to receive an email when new articles are posted on . Endoscopic mucosal resection followed by radiofrequency ablation had a better safety profile for managing ...
Doctors are using endoscopic submucosal dissection (ESD) to remove some early gastrointestinal tumors without making external cuts, a shift that can speed recovery and keep organs intact when cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results